Lidocaine


Amide local anesthetic and class IB antiarrhythmic

The prototype amide local anesthetic introduced in 1948, with concurrent indications as an intravenous antiarrhythmic and analgesic adjunct.

Abstract

Lidocaine (2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide; CAS 137-58-6; molecular formula C14H22N2O; molecular weight 234.34) is the prototype amide-class local anesthetic, synthesized by Nils Lofgren and Bengt Lundqvist at AB Astra in 1943 and introduced clinically in 1948 (Xylocaine). The compound replaced procaine and the ester-class anesthetics as the first-line choice owing to faster onset, longer duration, and substantially lower allergic potential (the amide linkage is metabolized hepatically rather than producing the para-aminobenzoic acid metabolite of ester anesthetics, the dominant allergen in that class). Mechanism is voltage-gated sodium channel blockade, predominantly at the inactivated state, with state-dependent kinetics that produce greater block in rapidly firing tissues (the basis for both local anesthetic action on small unmyelinated C fibers and antiarrhythmic action on ventricular tissue). The pKa is 7.9; at physiologic pH approximately 25 percent of the molecule is uncharged and able to cross neural and cardiac membranes, with reprotonation in the cytoplasm to engage the sodium channel pore from the intracellular side. Onset is fast (1 to 5 minutes for infiltration); duration is 1 to 2 hours unless coadministered with epinephrine, which extends duration to 3 to 4 hours through vasoconstriction and reduced systemic absorption. Antiarrhythmic indications are ventricular arrhythmias particularly in the postinfarction period; lidocaine is largely displaced by amiodarone in advanced cardiac life support but retains a role in specific contexts.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph